Study of Eyes and Attention Deficit (SEAD)

Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ADHD Accommodative Insufficiency Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Central Nervous System Diseases Convergence Insufficiency Cranial Nerve Diseases Eye Diseases Mental Disorders Nervous System Diseases Neurodevelopmental Disorders Ocular Motility Disorders

Age range

7 year–18 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Best corrected visual acuity of 20/25 in both eyes at distance and near;
Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;
500" random dot stereopsis

Exclusion criteria

Amblyopia (lazy eye);
Eye disease

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Registry information

Important dates

First posted: May 11, 2007
Registry last updated: Jul 3, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed